Truvian Health said its benchtop blood-testing device’s results are largely consistent with those generated by large central labs.

Jay Srinivasan, President and CEO of Truvian Health, sits down with Nasdaq's Kristina Ayanian to discuss Truvian Health's mission to provide unprecedented access to blood testing.

Truvian Health, a transformational and data-driven diagnostics company, today presented results from a recent multi-site clinical study at the 2023 Am ...

Truvian Health ("Truvian") is redefining the current global infrastructure through its novel platform, creating a world where central laboratory equivalent blood tests are available anywhere you go.

Truvian Health has raised $74 million to support a filing for clearance of its benchtop blood test instrument, the company said Wednesday. The device is designed to perform routine blood tests ...

News from Truvian Health Inc. that its benchtop blood testing platform can deliver results similar to those generated by central laboratory is promising for the diagnostic sector still coming to terms ...

Truvian, a blood testing platform company, raised $74 million in an unlabeled round led by venture capital firms Wittington Ventures and GreatPoint Ventures.

The research outputs (Count and Share) on this page only include articles according to the parameters listed below, to see all research outputs for Truvian view the complete profile. The research ...

SAN DIEGO, December 11, 2024--Truvian Health ("Truvian") today announced the appointment of Tina S. Nova, Ph.D., to its Board of Directors. Dr. Nova has more than two decades of experience serving as ...

Press Release Access to healthcare is a fundamental human right. Yet to this day, routine blood testing is limited across the globe. Truvian Health ("Truvian") is redefining the current global ...